These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 30725262)

  • 1. Linoleic Acid Metabolite DiHOME Decreases Post-ischemic Cardiac Recovery in Murine Hearts.
    Bannehr M; Löhr L; Gelep J; Haverkamp W; Schunck WH; Gollasch M; Wutzler A
    Cardiovasc Toxicol; 2019 Aug; 19(4):365-371. PubMed ID: 30725262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
    Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
    Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney.
    Lee JP; Yang SH; Lee HY; Kim B; Cho JY; Paik JH; Oh YJ; Kim DK; Lim CS; Kim YS
    PLoS One; 2012; 7(5):e37075. PubMed ID: 22590647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failure.
    Merabet N; Bellien J; Glevarec E; Nicol L; Lucas D; Remy-Jouet I; Bounoure F; Dreano Y; Wecker D; Thuillez C; Mulder P
    J Mol Cell Cardiol; 2012 Mar; 52(3):660-6. PubMed ID: 22155238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury.
    Jamieson KL; Darwesh AM; Sosnowski DK; Zhang H; Shah S; Zhabyeyev P; Yang J; Hammock BD; Edin ML; Zeldin DC; Oudit GY; Kassiri Z; Seubert JM
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpOMEs act as immune suppressors in a lepidopteran insect, Spodoptera exigua.
    Vatanparast M; Ahmed S; Lee DH; Hwang SH; Hammock B; Kim Y
    Sci Rep; 2020 Nov; 10(1):20183. PubMed ID: 33214688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble epoxide hydrolase: a new target for cardioprotection.
    Gross GJ; Nithipatikom K
    Curr Opin Investig Drugs; 2009 Mar; 10(3):253-8. PubMed ID: 19333883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
    Chaudhary KR; Abukhashim M; Hwang SH; Hammock BD; Seubert JM
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):67-73. PubMed ID: 19834332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450-derived linoleic acid metabolites EpOMEs and DiHOMEs: a review of recent studies.
    Hildreth K; Kodani SD; Hammock BD; Zhao L
    J Nutr Biochem; 2020 Dec; 86():108484. PubMed ID: 32827665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury.
    Bergmann CB; McReynolds CB; Wan D; Singh N; Goetzman H; Caldwell CC; Supp DM; Hammock BD
    Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2120691119. PubMed ID: 35312372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Deletion or Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Cardiac Ischemia/Reperfusion Injury by Attenuating NLRP3 Inflammasome Activation.
    Darwesh AM; Keshavarz-Bahaghighat H; Jamieson KL; Seubert JM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31319469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.
    Islam O; Patil P; Goswami SK; Razdan R; Inamdar MN; Rizwan M; Mathew J; Inceoglu B; Stephen Lee KS; Hwang SH; Hammock BD
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28296232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The oxidized linoleic acid metabolite 12,13-DiHOME mediates thermal hyperalgesia during inflammatory pain.
    Zimmer B; Angioni C; Osthues T; Toewe A; Thomas D; Pierre SC; Geisslinger G; Scholich K; Sisignano M
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):669-678. PubMed ID: 29625231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
    Olearczyk JJ; Field MB; Kim IH; Morisseau C; Hammock BD; Imig JD
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1307-14. PubMed ID: 16772540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
    Dorrance AM; Rupp N; Pollock DM; Newman JW; Hammock BD; Imig JD
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment.
    Yu D; Hennebelle M; Sahlas DJ; Ramirez J; Gao F; Masellis M; Cogo-Moreira H; Swartz RH; Herrmann N; Chan PC; Pettersen JA; Stuss DT; Black SE; Taha AY; Swardfager W
    Transl Stroke Res; 2019 Oct; 10(5):522-533. PubMed ID: 30443886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble epoxide hydrolase: a novel therapeutic target in stroke.
    Zhang W; Koerner IP; Noppens R; Grafe M; Tsai HJ; Morisseau C; Luria A; Hammock BD; Falck JR; Alkayed NJ
    J Cereb Blood Flow Metab; 2007 Dec; 27(12):1931-40. PubMed ID: 17440491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble epoxide hydrolase inhibitor enhances synaptic neurotransmission and plasticity in mouse prefrontal cortex.
    Wu HF; Yen HJ; Huang CC; Lee YC; Wu SZ; Lee TS; Lin HC
    J Biomed Sci; 2015 Oct; 22():94. PubMed ID: 26494028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
    Jung O; Brandes RP; Kim IH; Schweda F; Schmidt R; Hammock BD; Busse R; Fleming I
    Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress.
    Batchu SN; Lee SB; Samokhvalov V; Chaudhary KR; El-Sikhry H; Weldon SM; Seubert JM
    Can J Physiol Pharmacol; 2012 Jun; 90(6):811-23. PubMed ID: 22624559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.